LTGO
Latigo Biotherapeutics, Inc. Common Stock
Nasdaq · usd
Latigo Biotherapeutics, Inc. Common Stock (LTGO) trades at $13.31 (-3.27%) as of 5:19:44 PM EST on Nov 18, 2026, -12.72% over the past month. Market cap is $882.44M, with 5.4 days to cover in short interest.
Stock performance
How Latigo Biotherapeutics, Inc. Common Stock (LTGO) stock has performed from one day to one year, with its 52-week range.
- 1D
- -3.27%
- 1W
- -1.55%
- 1M
- -12.72%
- YTD
- -27.07%
- 1Y
- -27.07%
- 52-wk range
- $10.24 – $25.93
Key statistics
Today's trading snapshot for LTGO: day range, open, previous close, volume and market cap.
- Day range
- $13.21 – $14.26
- Open
- $14.00
- Prev close
- $13.76
- Volume
- 209.1K
- Market cap
- $882.44M
- Shares out
- 66.3M
8-K filings
Material corporate events Latigo Biotherapeutics, Inc. Common Stock has disclosed to the SEC on Form 8-K.
- Quarterly earningsNov 5, 2026
On November 5, 2026, Latigo Biotherapeutics, Inc. (the "Company") issued a press release announcing its financial results for the quarter ended September 30, 2026.
- Quarterly earningsSep 3, 2026
On September 3, 2026, Latigo Biotherapeutics, Inc. (the "Company") issued a press release announcing its financial results for the quarter ended June 30, 2026.
- Public offeringAug 10, 2026
On August 10, 2026, the Company completed its IPO of an aggregate of 19,200,000 shares of common stock at a price to the public of $18.00 per share. The aggregate gross proceeds from the IPO, before deducting underwriting discounts and commissions and estimated offering expenses payable by the Company, were approximately $345.6 million.
LTGO short interest
How heavily LTGO is shorted: shares short, days to cover and average daily volume.
- Days to cover
- 5.4
- Short interest
- 941.43K
- Avg volume
- 173.41K
As of · reported to FINRA twice monthly.
Frequently asked questions
What is the Latigo Biotherapeutics, Inc. Common Stock (LTGO) stock price today?
Latigo Biotherapeutics, Inc. Common Stock (LTGO) is trading at $13.31 (-3.27% on the day) as of 5:19:44 PM EST on Nov 18, 2026. Prices are delayed at least 15 minutes; real-time quotes are available from the Massive API.
What is Latigo Biotherapeutics, Inc. Common Stock?
Latigo Biotherapeutics Inc is a clinical-stage biotechnology company focused on developing non-opioid pain medicines designed to rapidly and effectively stop the transmission of pain without the risk of addiction.
What is the short interest in LTGO?
As of Oct 30, 2026, LTGO has 941.43K shares short and 5.4 days to cover.
What exchange is LTGO listed on?
Latigo Biotherapeutics, Inc. Common Stock (LTGO) trades on Nasdaq in USD, in the PHARMACEUTICAL PREPARATIONS industry.
Build with AI
Build an analysis of LTGO with your agent
Point Claude or ChatGPT at the Massive MCP server and recreate this page from live data.
Connect the Massive MCP server (API reference: massive.com/docs/llms.txt) and build a LTGO analysis: the latest quote, key ratios (P/E, P/S, ROE), short interest, recent insider activity and the latest news.
Nothing on this page is investment advice. All data and content is provided for informational purposes under our Terms of Service.